Propranolol Dosing in Adults Without Renal or Hepatic Impairment
For adults without renal or hepatic impairment, start propranolol immediate-release at 30-80 mg daily in divided doses (or 80 mg once daily for extended-release formulations), with typical maintenance doses ranging from 80-160 mg daily depending on the indication, and maximum doses up to 640 mg daily for certain conditions. 1, 2, 3
Indication-Specific Dosing Recommendations
Cardiovascular Indications
Hypertension:
- Initial dose: 80 mg once daily (extended-release) or 80-160 mg daily divided into 2 doses (immediate-release) 2, 3
- Maintenance dose: 120-160 mg once daily (extended-release) 3
- Maximum dose: Up to 640 mg daily may be required in some cases 3
- The time needed for full hypertensive response is variable and may range from a few days to several weeks 3
Supraventricular Tachycardia (SVT) - Ongoing Oral Therapy:
- Initial dose: 30-60 mg daily in divided doses or as a single dose with long-acting formulations 1
- Maintenance dose: 40-160 mg daily in divided or single dose with long-acting formulations 1
- This represents the ACC/AHA/HRS guideline recommendation for rate control 1
Angina Pectoris:
- Initial dose: 80 mg once daily (extended-release) 3
- Titration: Increase gradually at 3-7 day intervals until optimal response 3
- Average optimal dose: 160 mg once daily 3
- Maximum dose: Safety and efficacy beyond 320 mg daily have not been established 3
Atrial Fibrillation Rate Control:
- Dose: 10-40 mg immediate-release, 3-4 times daily 2
Anxiety and Performance-Related Indications
Ongoing Anxiety Treatment:
- Initial dose: 40 mg twice daily (80 mg total daily) of immediate-release formulation 2
- Alternative: 80 mg once daily of long-acting formulation, titrated to 120-160 mg once daily 2
- Typical effective range: 80-160 mg daily in 2 divided doses 2
- Lower doses of 10-40 mg three or four times daily may be sufficient for some patients while minimizing side effects 2, 4
Situational/Performance Anxiety:
- Dose: 10-40 mg taken 30-60 minutes before the anxiety-provoking event 2, 5
- Maximum single dose: 40 mg 5
- This is specifically for patients with prominent somatic symptoms (tremor, palpitations, sweating) rather than chronic anxiety 5
Essential Tremor
- Therapeutic range: 80-240 mg daily 2
- Maximum dose: Up to 240 mg daily if needed for adequate tremor control 2
Migraine Prophylaxis
- Initial dose: 80 mg once daily (extended-release) 3
- Usual effective range: 160-240 mg once daily 3
- If satisfactory response is not obtained within 4-6 weeks after reaching maximal dose, discontinue therapy 3
Formulation-Specific Considerations
Immediate-Release vs. Extended-Release:
- Immediate-release half-life: 3-6 hours, requiring 2-4 times daily dosing 2
- Extended-release half-life: 8-20 hours, allowing once daily dosing 2
- Extended-release formulations are NOT simple mg-for-mg substitutes for immediate-release tablets due to different kinetics and lower blood levels 3
- Retitration may be necessary when switching formulations, especially to maintain effectiveness at the end of the 24-hour dosing interval 3
Mandatory Pre-Treatment Assessment
Screen for Absolute Contraindications: 1, 2, 5
- Second or third-degree heart block
- Decompensated heart failure or severe left ventricular dysfunction
- Asthma or obstructive airway disease
- Cardiogenic shock
- Sinus node dysfunction without pacemaker
- Severe bradycardia or hypotension
Baseline Cardiovascular Assessment: 2, 5
- Measure heart rate and blood pressure
- Perform cardiovascular examination with auscultation
- ECG and echocardiogram are only required in patients with suspected cardiac abnormalities, cardiac symptoms, abnormal heart rate, or family history of sudden death 2, 5
- Routine blood work (CBC, renal, liver, thyroid function) is NOT required in otherwise healthy adults 5
Screen for Relative Contraindications: 5
- History of bronchospasm
- Diabetes (propranolol masks hypoglycemia symptoms)
- Concurrent medications affecting cardiac conduction
Critical Safety Principles
Administration Guidelines:
- Administer with food to reduce hypoglycemia risk, particularly in patients with diabetes 2, 5
- Hold doses during diminished oral intake or vomiting 2, 5
Discontinuation Protocol:
- Never abruptly discontinue propranolol after chronic use 2, 5, 4, 3
- Taper gradually over several weeks to prevent rebound hypertension, tachycardia, or angina 2, 5, 4
- Reduce dosage gradually over a period of a few weeks when discontinuing 3
Monitoring During Treatment:
- Monitor for hypotension and bradycardia, especially during dose escalation 2, 5
- Watch for signs of excessive beta-blockade: dizziness, extreme fatigue, syncope 2, 4
- No routine vital sign monitoring required between appointments if patient is stable and asymptomatic 5
- Hypotension
- Bradycardia
- Bronchospasm
- Worsening heart failure
- Fatigue
- Dizziness
- Cold extremities
Special Population Considerations
Elderly Patients:
- Start at lower doses (40 mg twice daily or 80 mg extended-release) 2, 4
- Titrate more gradually due to increased sensitivity to beta-blockers 2, 4
- May require lower maintenance doses due to altered pharmacokinetics 5
Diabetic Patients:
- Use with extreme caution in patients with diabetes or history of hypoglycemic episodes 5
- Propranolol masks symptoms of hypoglycemia (tremor, tachycardia) 5
Important Drug Interactions
Avoid Routine Combination With:
- Non-dihydropyridine calcium channel blockers (diltiazem, verapamil) due to increased risk of bradycardia and heart block 1, 5
Use Caution With:
- Other drugs with SA and/or AV nodal-blocking properties 1
Common Pitfalls to Avoid
- Starting with too high a dose: Begin at the lower end of the dosing range and titrate gradually 2, 3
- Abrupt discontinuation: Always taper over several weeks 2, 5, 4, 3
- Assuming formulation equivalence: Extended-release is NOT a simple mg-for-mg substitute for immediate-release 3
- Inadequate screening: Always screen for contraindications, particularly asthma and heart block 1, 2, 5
- Using for wrong anxiety type: Propranolol is most effective for situational anxiety with somatic symptoms, not generalized anxiety disorder 5